CTEV

Claritev

Fundamental data last updated:April 13, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Healthcare

industry

Health Information Services

Exchange

NYSE

County of HQ

United States

Next Earnings Date

05/14/26

Business Summary

Concentrix generates revenue by providing outsourced customer experience, technical support, and business process services to enterprise clients, monetizing long-term service contracts and global delivery infrastructure. Its moat is rooted in scale, embedded client relationships, and the operational complexity of managing multilingual, multi-channel customer engagement at enterprise level. Switching costs arise from integration into clients’ workflows and data systems, which can create sticky recurring revenue streams. However, the business ultimately lives and dies on execution efficiency—labor management, technology enablement, and margin discipline determine whether scale converts into durable free cash flow.

 


Analyze CTEV on TradingView

VALUATION

P/E

-

Market Cap ($M USD)

$275

Forward P/E

2.4

PEG

-

PRICE TO SALES

0.3

PRICE TO BOOK

-

EV / EBITDA

10.4

5-Year Average P/E

Free Cash Flow Yield

DCF Value

Graham Number

Price to FCF

EV to FCF

Earnings Yield

FCF Yield

DIVIDEND

Yield

-

Annual Payout

-

Payout Ratio

-

Consecutive Years of Dividend Growth

0

5-Year Dividend Growth Rate

-

Financial Health & Profitability

Earnings Per Share

-$17.30

Next Year EPS Growth Estimate

$6.84

Next Year Revenue Growth Estimate

4.50%

Return on Equity (ROE)

163.50%

FREE CASH FLOW

Operating Margin

4.70%

Debt-to-Equity

-

Piotroski F-Score

4

Altman Z-Score

-0.4

Return on Invested Capital (ROIC)

2.40%

Current Ratio

0.9

Quick Ratio

Net Debt to EBITDA

Interest Coverage

Gross Profit margin

FCF PER SHARE

REVENUE PER SHARE

Analyze CTEV on TradingView

Gainseekers Quantitative Analysis

Summary

CNXC screens like a statistically cheap but fundamentally stressed deep value situation. A Forward P/E of 2 and a PEG Forward of 0.3 scream extreme compression, yet the market is reacting to a brutal earnings profile with EPS at -20.2 and EPS Next Year (Est.) at -$21.07, combined with an Operating Margin of -47.70% and ROIC of -13.80%. The Altman Z-Score of 1.3 places the company in distress territory, and with Debt / Equity at 5.60%, this is not a clean balance sheet story. At 0.2x sales and 0.6x book, the stock looks mispriced optically cheap, but the low multiple is a reflection of solvency risk rather than hidden growth. This is a high-risk balance sheet turnaround trading at distressed valuations, not a stable compounder.

AI Exposure / Tech Reliance

As an Information Technology Services company, CNXC operates in a segment directly exposed to automation, AI-enabled customer engagement, and digital outsourcing transformation. AI can both compress labor-heavy margins and create efficiency leverage, making execution critical in a business already showing a -47.70% Operating Margin. The ability to pivot service delivery toward AI-augmented solutions will determine whether the current Forward P/E of 2 reflects a trough or a trap.

The Bull Case

A deep value or GARP investor could argue the asymmetry is compelling: a Price / Sales of 0.2 and Price / Book of 0.6 imply liquidation-level pricing for a company with $1,593M in market cap and 41.25% institutional ownership. The Piotroski F-Score of 5 signals middling but not catastrophic fundamental quality, suggesting stabilization rather than collapse. Return on Equity at 2.40%, while weak, remains positive despite a -20.2 EPS print, and a Current Ratio of 1.2 indicates short-term liquidity is not yet broken. With a TTM Yield of 1.7 and Dividend 5-Year Avg (%) of 4, income investors may see a reset opportunity if margins normalize even modestly, particularly given the ultra-low Forward P/E of 2 pricing in severe pessimism.

The Bear Case

The bear case is overwhelming: Operating Margin at -47.70% and ROIC at -13.80% indicate capital destruction, not cyclical weakness. Debt / Equity of 5.60% combined with an Altman Z-Score of 1.3 signals genuine balance sheet fragility, and EPS Next Year (Est.) at -$21.07 suggests losses are not abating. A Payout Ratio of $1.44 alongside negative earnings raises sustainability concerns around the 5.30% Dividend Per Share USD figure and 1.7 TTM Yield. With Sales Growth Next Year listed at $12.84 but profitability deeply negative, the company risks growing revenue without restoring economic value, a classic value trap profile.

Market Sentiment & Smart Money

Short Interest %

11.90%

Analyst Consensus

1.8

Average Analyst Price Target

$42.75

Institutional Ownership %

91.10%

1-Year Beta

1.66

Insider Buying % (6 Mo)

7.00%%

Distance to 52-Week High

21.90%

Distance to 52-Week Low

134.90%

EARNINGS SURPRISE %

50-DAY SMA

200-DAY SMA

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.